A conundrum of regulatory issues and decisions in coming months threaten to stifle community retail pharmacy’s goal of advancing patient access to health care services designed to lower overall costs. These include anticompetitive practices of third-party pharmacy benefit management (PBM) companies, federal and state cuts to pharmacy reimbursement rates, drug safety issues and access to Medication Therapy Management services. First off there is the $29 billion Express ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.